Resources

At present the FDA allows an error rate of blood glucose meters at 20%…. 

Women with high levels of the liver enzyme gamma-glutamyl transferase before pregnancy may be more likely to develop gestational diabetes than those with lower levels…. 

Kathie L. Hermayer, MD, and Pam Arnold, MSN, talk about how the MUSC program was integrated into the existing electronic records system and that further progress is being made on this front so that physicians and other healthcare providers will have access to their patients’ data…..

Kathie L. Hermayer, MD, and Pam Arnold, MSN, talk about the change in the rate of hypoglycemia now seen in the MUSC system, which has decreased from around 10% to 2%. They emphasize, however, that the work is far from over, and that there is further opportunity for improvement, especially …

Kathie L. Hermayer, MD, and Pam Arnold, MSN, explain that, in the MUSC program to control hypoglycemia, they did not see increases in incidence of hyperglycemia. Instead, they did train staff to more gradually raise low blood sugars,  also changing some of the existing protocols slightly in order not to …

Kathie L. Hermayer, MD, and Pam Arnold, MSN, discuss the various reasons for hypoglycemia and how they had to encourage staff to change some of their ways of thinking including training they had received previously….

 Kathie L. Hermayer, MD, and Pam Arnold, MSN, talk about the Medical University of South Carolina’s program working toward lowering rates of hypoglycemia in a hospital setting and the importance of this goal. Because controlling hypoglycemia is so dangerous, one of the first things they aimed for was to lower …

Kathie L. Hermayer, MD, MS, and Pam Arnold, MSN, PNP, APRN, BC-ADM, CDE, give us a brief introduction to themselves, explaining how they work together and what they do at the Medical University of South Carolina in the Hospital Diabetes Task Force Program.

  This week we wrap up our series of Homerun Slides from Dr. Stanley Schwartz covering the current state of obesity and the medication therapies available. We delve further in to the possibilities of combining insulin with the new incretin therapies including GLP-1’s and DPP-IV’s….

Richard S. Beaser, MD This week’s excerpt cover the following topics: Why a patient should start with multiple medications How much treatment is needed When to use combination therapy